-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Reiterates Buy on Actinium Pharma, Maintains $4 Price Target

Benzinga·04/28/2025 17:28:02
Listen to the news
HC Wainwright & Co. analyst Joseph Pantginis reiterates Actinium Pharma (AMEX:ATNM) with a Buy and maintains $4 price target.